|
HS Code |
723714 |
| Product Name | Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid |
| Cas Number | 1359224-29-5 |
| Molecular Formula | C10H8BrNO2 |
| Molecular Weight | 254.08 |
| Appearance | Off-white to light brown solid |
| Purity | Typically >95% |
| Smiles | COC(=O)c1cc2cc[nH]c2cc1Br |
| Inchi | InChI=1S/C10H8BrNO2/c1-14-10(13)8-3-6-2-4-12-9(6)5-7(8)11/h2-5,12H,1H3 |
| Solubility | Slightly soluble in DMSO, DMF |
| Storage Temperature | 2-8°C |
As an accredited Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every so often in the life of a chemist, you meet a compound that rewrites what’s possible in the lab. For years, I’ve watched indole derivatives shape the frontiers of medicinal and materials science. Among these, Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid has become a frequent companion in workloads demanding accuracy and reliability. This compound, with its unique 4-bromo substitution, has proven its strength as a building block that supports research across several challenging fields—whether crafting new drug candidates or constructing advanced organic materials.
Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid doesn’t camp out in obscure journals—it has found a firm foothold in labs focused on discovery. People ask what really gives this molecule its edge. The answer begins in its structure. The indole core has served as a creative platform since natural products like tryptophan and serotonin became topics in undergraduate biochemistry. Adding a methyl ester at the carboxyl end changes its reactivity profile, often saving time in downstream reactions, and streamlining synthesis routes that can otherwise mire researchers in side reactions or unwieldy intermediates.
The 4-bromo group offers another upgrade. Bromine is a notorious “handle” for chemists. It sets the stage for classic coupling strategies like Suzuki or Stille reactions, which let you append more complex groups to the core framework. High selectivity at the 4-position allows synthetic plans to take on true sophistication—a far cry from the random, shotgun-style chemistry that dominated early organic synthesis. This selectivity means fewer by-products, less purification, and more predictable routes to target molecules. Through repeated use, it’s become clear this compound gives practical value by cutting overhead in reaction steps and purification demands.
Trust grows where quality can be measured. Over my years handling Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid, I’ve taken note of consistent purity standards. Impurities are more than minor annoyances; in drug or catalyst development, micrograms out of place can turn failure into tragedy. Reliable suppliers understand this, maintaining thin tolerances. Those who work with analytical labs often verify each batch using HPLC and nuclear magnetic resonance, a habit I’ve kept since a bad experience with a contaminated reagent once led to weeks of lost experiments.
Storage calls for attention as well. While Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid is not overly sensitive to light or oxygen, I keep mine in an amber vial inside a desiccator, away from swings in humidity. Neglecting conditions leads to slow hydrolysis of the ester group or, sometimes, oxidative discoloration at the indole ring. Many of us have learned to protect our investments, not from any marketing directive, but from experience and the hard lessons of costly reruns.
Ask any medicinal chemist how they rank their favorite building blocks; indoles always make the shortlist. Their aromatic stability, planarity, and predictable behavior in reactions give project leads confidence to map bold molecular designs. Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid stands out with its combination of electron-withdrawing and donating groups, yielding a molecule receptive to a broad family of reagents. In contrast to unsubstituted indoles, the 7-carboxylic acid methyl ester slows certain side reactions—think of it as tweaking the stereo for less noise in your playlist—while the 4-bromo lets the chemist play conductor, choosing the next transformation with a lighter touch.
Often, someone working on kinase inhibitors or biologically active peptidomimetics needs not just an indole, but one amenable to direct modifications at positions that matter for binding or activity. Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid delivers on that need. In my circle, few molecules see as much creative use or elicit as much tactical discussion during the group meeting whiteboard sessions.
A closer look at its formula—C10H8BrNO2—shows the balance of functionality chemists seek. Methyl ester and bromine act as switches, letting you toggle between nucleophilic attack, electrophilic additions, or even photochemical manipulations. These aren’t just reactions in a textbook—they’ve shown up in my experience creating extended conjugated systems for organic electronics, where electron flow depends on substituent effects. In one project, I found that the presence of the 7-carboxylic acid methyl ester helped control the placement of functional groups, avoiding clashing interactions, and supporting more predictable electron delocalization across the molecule.
The story goes beyond just theory. Many research groups have published stepwise protocols transforming this compound into fused heterocycles or linking it with small peptides for biochemical screening. What really impresses in these reports isn’t just novelty, but the way Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid stands up to scale. Small test reactions work as expected, then quickly scale up for larger batches with minimal need for reaction redesign. Anyone who’s ever suffered through a scale-up gone wrong will appreciate how much pain this saves.
Other indole-containing acids and esters populate chemical catalogs. Sifting through them exposes the differences that matter in practical chemistry. The parent compound, indole-7-carboxylic acid, lacks the 4-bromo handle—this limits its versatility in modular synthesis. Methyl esters like 1H-Indole-7-carboxylic acid methyl ester have some of the utility, but don’t handle coupling reactions without extra steps, often pushing up both labor and risk of yield loss.
Compared to common 3-bromo indoles, this 4-bromo derivative offers complementary reactivity. In certain applications, like the design of asymmetrical ligands, the difference between functionalizing at the 3- or 4-position can mean the difference between a working drug and an inactive analog. My own experiments with 4-bromo indoles have furnished several selective inhibitors that 3-bromo analogs failed to provide, simply because of spatial constraints around the binding pocket. There’s a lesson in this for anyone pushing beyond mimicry, into the zone of true innovation.
Working in preclinical drug development stays unpredictable. Some weeks, the focus lies on synthesizing precursors for a panel of bioassays, where every substitution counts. In my projects, Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid has nudged open new directions, particularly where modifications at the 4-position unlock better metabolic stability or tweak pharmacokinetics for specific targets. Colleagues in material science have echoed similar findings, using this framework to lay down functionalized indoles for organic light-emitting diodes and photovoltaic materials.
Academic groups have cited this compound in syntheses of unique pyrrolo[2,3-f]indole cores, which serve as scaffolds for anti-cancer and anti-viral agents. Researchers value the way its functional groups open doors to more challenging cross-couplings or selective oxidations, where competing side products otherwise rule out less tailored indole derivatives.
Safety in the lab starts with respect for every chemical, no matter how familiar. Over time, handling Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid brings a few reminders. The compound has a moderate toxicity profile, so gloves and goggles stay non-negotiable. Good airflow gets rid of any lingering dust, and spills clean up fast with a bit of care and the right absorbent. Years back, I saw complacency on bench safety cost a bright student a ruined set of samples—hygroscopic substances drift, contaminating neighboring reagents faster than people expect. Clear rules and careful habits kept our bench running without these avoidable setbacks.
Disposal processes matter, too. Solutions and scraps with methyl esters or bromine content get collected separately for hazardous waste disposal. Getting this right not only follows regulations but also protects the reputation of any research group or company. Environmental stewardship asks the same commitment from everyone in the lab, and tracking solvents or residues has become second nature. Mistakes shrink when documentation stays close at hand—something all newcomers quickly learn in the trenches.
There’s no reward for guesswork in complex synthesis. As research demands grow—whether pursuing green chemistry objectives or overcoming resistance in targeted therapies—chemists depend on every lever available to them. That often means selecting starting materials with both flexibility and reliability. Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid embodies this approach. In my own work, its use has reduced overall synthetic steps and delivered precursors with fewer impurities, which translates to clearer assay outcomes and faster progress from speculation to published result.
Supply chain predictability can throw unexpected challenges in the way of any team’s timeline. Building stock of compounds like this one, with verified provenance and supporting analytical data, steadies the ship against those disruptions. Asking for full traceability from suppliers, and keeping detailed internal logs of batch numbers and quality checks, keeps costly mishaps from derailing tight schedules. It’s a discipline that serves teams, especially in high-throughput or clinical-prep environments where every error echoes downstream.
Over the last decade, the tools to analyze complex molecules have radically improved. NMR and LC-MS let chemists profile their intermediates and products in far more detail than in the early days. In my experience, suppliers who document analytical spectra for each batch offer confidence in what arrives—reducing batch variability to the occasional hiccup, not a chronic headache. Transfer of this information needs to cut both ways; feedback from researchers in the field helps identify contamination sources, storage issues, and even subtle differences in synthetic route byproducts.
Open data practices don’t stop at the lab door; publishing detailed procedures and characterization data ensures reproducibility. In collaborative projects, I’ve seen how early sharing of full spectral data, not just summary analyses, staves off confusion and costly dead-ends. As labs coordinate across borders and time zones, trust in every reagent, starting with its profile and performance record, becomes more valuable than ever. Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid has grown into a clear favorite, precisely because it travels well through these rigorous checkpoints.
My own story with Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid includes late nights in the lab, troubleshooting reactions that read fine on paper but stubbornly refused to work with less adaptable analogs. There’s nothing quite like the satisfaction of getting a reaction going on the first try, watching TLC plates light up as anticipated. Even the best literature methods still need a real-world touch, tuning solvent ratios, temperatures, and work-up conditions to make everything hum smoothly.
Conversations with colleagues echo this theme—success comes from matching the right agent to the particular quirks of a synthesis, not just picking from a catalog. Small features in molecular structure, like the position of a bromo substituent, alter outcomes more profoundly than textbook retrosynthesis can predict. Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid has proven its worth by repeatedly supporting new approaches that would have foundered using less specialized indole derivatives. That kind of pattern, built on daily experience, outshines abstract theorizing any day.
Mentoring junior chemists on my team always brings up questions about reagent choice. I’ve found that discussing the proven track record and reliable reactions of this compound forms part of their foundation in practical synthesis. Demonstrating good practice—double-checking catalog numbers, inspecting material before use, logging details for every step—builds habits that serve them well throughout their careers. Nothing beats hands-on learning, but starting with the right tools makes that learning curve far less steep.
Safety briefings include case studies on past incidents and how quality assurance at every stage makes labs both safer and more productive. Newcomers catch on quickly to the benefit of using reagents like Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid, which not only reduce side reactions but also lower the risks associated with unpredictable impurities. Watching them apply these lessons, crafting new molecules that show up in better yields and cleaner spectra, highlights the way thoughtful choices build stronger research from the ground up.
The influence of a robust reagent extends past single-use experiments. In my collaborations with industry partners developing pharmaceuticals and advanced polymers, using trusted compounds speeds up scale-up and approval processes. Consistency and transparency matter as much to regulatory reviewers as to synthetic chemists. It’s in these joint ventures, facing stringent quality standards, that Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid earns its keep.
No single molecule will solve every synthetic challenge, but picking high-performance intermediates starts a ripple effect that helps teams push toward faster innovation. Reviewing data packages from recent regulatory submissions, I noticed a pattern—processes that began with trusted reagents like this one were the ones least likely to need reruns, amendments, or supplementary documentation. The compound’s clear analytical profile, well-understood behavior, and known supply routes created a smoother path from idea to viable product.
Innovation happens at the edge of the unknown. Working with Methyl 4-Bromo-1H-Indole-7-Carboxylic Acid, I’ve seen scientists thrive with fewer roadblocks standing between concept and delivered result. Certainly, new reagents emerge all the time, sporting even more creative substitution patterns or reactivity. Yet time and again, this particular indole derivative shows up in the hands of researchers who want trusted outcomes without sacrificing the scope of their investigation.
As the pace of discovery accelerates, foundational materials with predictable performance help scientists devote more energy to unexplored frontiers, not troubleshooting avoidable setbacks. Having put this compound through its paces across dozens of projects, I can say that such reliability pays off—whether in drug pipeline advancement, material innovation, or the simple satisfaction of seeing an experiment work as planned. Every field evolves, and staying at the top means never taking reagents for granted, no matter how familiar or well-reviewed they may be.